BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

MT Newswires Live10-02

BriaCell Therapeutics (BCTX) shares plummeted more than 40% in recent trading on Tuesday after the company priced a $5 million offering of common shares and warrants.

The company said it priced the offering of about 5.12 million shares and warrants to buy roughly 5.12 million shares at $0.975 per share and associated warrant.

Warrants in the offering can be exercised for $0.85 to purchase one share of the company immediately after issuance and expire after five years, BriaCell added.

The company said it expects to close the offering on Wednesday and use the proceeds from the offering for working capital requirements, general corporate purposes, and advance business objectives.

Price: 0.74, Change: -0.50, Percent Change: -40.08

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2472585614?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-02 02:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472585614","market":"fut","top_or_hot":-1,"title":"BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering","media":"MT Newswires Live","content":"<html><body><p> BriaCell <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (BCTX) shares plummeted more than 40% in recent trading on Tuesday after the company priced a $5 million offering of common shares and warrants.</p><p>The company said it priced the offering of about 5.12 million shares and warrants to buy roughly 5.12 million shares at $0.975 per share and associated warrant.</p><p>Warrants in the offering can be exercised for $0.85 to purchase one share of the company immediately after issuance and expire after five years, BriaCell added.</p><p>The company said it expects to close the offering on Wednesday and use the proceeds from the offering for working capital requirements, general corporate purposes, and advance business objectives.</p><p>Price: 0.74, Change: -0.50, Percent Change: -40.08</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-02 02:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BriaCell Therapeutics (BCTX) shares plummeted more than 40% in recent trading on Tuesday after the company priced a $5 million offering of common shares and warrants.The company said it priced the ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2472585614","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472585614","pubTimestamp":1727808943,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BriaCell Therapeutics  shares plummeted more than 40% in recent trading on Tuesday after the company priced a $5 million offering of common shares and warrants.The company said it priced the offering of about 5.12 million shares and warrants to buy roughly 5.12 million shares at $0.975 per share and associated warrant.Warrants in the offering can be exercised for $0.85 to purchase one share of the company immediately after issuance and expire after five years, BriaCell added.The company said it expects to close the offering on Wednesday and use the proceeds from the offering for working capital requirements, general corporate purposes, and advance business objectives.Price: 0.74, Change: -0.50, Percent Change: -40.08","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BCTX":"BriaCell Therapeutics Corp.","LENZ":"Therapeutics"},"translate_title":"BriaCell Therapeutics定价500万美元后股价暴跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BCTX":1,"LENZ":1},"content_text":"BriaCell Therapeutics (BCTX) shares plummeted more than 40% in recent trading on Tuesday after the company priced a $5 million offering of common shares and warrants.The company said it priced the offering of about 5.12 million shares and warrants to buy roughly 5.12 million shares at $0.975 per share and associated warrant.Warrants in the offering can be exercised for $0.85 to purchase one share of the company immediately after issuance and expire after five years, BriaCell added.The company said it expects to close the offering on Wednesday and use the proceeds from the offering for working capital requirements, general corporate purposes, and advance business objectives.Price: 0.74, Change: -0.50, Percent Change: -40.08","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2472585614"}